1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

22 Dec 2021
Admin
News Article

Usfda Approves Injectable Form Of Gsk Hiv Prevention Drug

The Injection - Apretude - To Prevent The Virus That Causes Aids Is Aimed As An Alternative To Daily Pills And Has Been Approved For Use In At-Risk Adults And Adolescents U.S. Food And Drug Administration (Fda) On Monday Approved An Injectable Form Of Glaxosmithkline Plc'S Cabotegravir Drug That Is Given Every Two Months To Prevent An Hiv Infection. The Injection - Apretude - To Prevent The Virus That Causes Aids Is Aimed As An Alternative To Daily Pills And Has Been Approved For Use In At-Risk Adults And Adolescents. Its First Two Doses Are Administered One Month Apart And Then The Injection Is Given Usfda Approves Injectable Form Of Gsk Hiv Prevention Drug, Health News, Food And Drug Administration Oral Pills Hiv Test Health News Glaxosmithkline Plc Aids Every Two Months Thereafter. Patients Can Start Their Treatment With Apretude Or Take Oral Cabotegravir For Four Weeks To Assess How Well They Tolerate The Drug. Apretude Comes With A Boxed Warning To Not Use The Drug Unless A Negative Hiv Test Is Confirmed. A Boxed Warning On The Label Is Fda'S Strictest Warning And Calls Attention To Serious Or Life-Threatening Risks Of A Drug. Apretude'S Approval Was Based On A Final Study Showing It Was Found To Be 66% More Effective In Preventing Hiv Infections Than Gilead'S Truvada Daily Oral Pills. Cabotegravir And The Daily Oral Pill Were Both Well Tolerated In The Study, Which Was Conducted On Men Who Engage In Sexual Activity With Other Men And Transgender Women Who Have Sex With Men, Putting Them At Risk Of Contracting Hiv

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!